Predict your next investment

Investment Bank
FINANCIAL | Investment Banking
huaxing.com

See what CB Insights has to offer

Investments

80

Portfolio Exits

14

Funds

12

Partners & Customers

5

About China Renaissance

China Renaissance (HK: 1911) is an independent investment bank in China focused on providing strategic and financial advice to Chinese entrepreneurs and financial sponsors across a broad range of sectors, with a particular specialization in TMT, Healthcare and Consumer. Its services include private fund-raisings, public offerings, mergers & acquisitions, sales, trading and equity research.

China Renaissance Headquarter Location

Pacific Century Place, Gate 1, Space 8 No.2A Workers’ Stadium North Road, Chaoyang District

Beijing, Beijing, 100027,

China

+86 10 8567 9988

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

China Renaissance Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

China Renaissance Rank

Research containing China Renaissance

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned China Renaissance in 1 CB Insights research brief, most recently on Sep 11, 2019.

Latest China Renaissance News

DealShot: 16 Deals Topping $1.5 Billion With Sequoia, China Renaissance And Many More

Oct 26, 2021

All Rights Reserved. Disclaimer: The views, opinions, forecasts, and statements made by our hosts and guests are the personal views of those respective individuals and may or may not be either endorsed or accepted by China Money Network Limited or the companies with which these individuals are employed.

China Renaissance Investments

80 Investments

China Renaissance has made 80 investments. Their latest investment was in Huayin APP as part of their Series B - II on November 11, 2021.

CBI Logo

China Renaissance Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/29/2021

Series B - II

Huayin APP

No

5

11/1/2021

Series B

Huayin APP

Yes

5

10/14/2021

Series D

Creative Biosciences

$86.96M

Yes

7

10/12/2021

Series B

Subscribe to see more

$99M

Subscribe to see more

10

9/8/2021

Series C

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/29/2021

11/1/2021

10/14/2021

10/12/2021

9/8/2021

Round

Series B - II

Series B

Series D

Series B

Series C

Company

Huayin APP

Huayin APP

Creative Biosciences

Subscribe to see more

Subscribe to see more

Amount

$86.96M

$99M

$99M

New?

No

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

5

5

7

10

10

China Renaissance Portfolio Exits

14 Portfolio Exits

China Renaissance has 14 portfolio exits. Their latest portfolio exit was ANE Logistics on November 11, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

11/11/2021

IPO

3

8/16/2021

Acquired - II

$991

2

6/25/2021

IPO

$991

1

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

11/11/2021

8/16/2021

6/25/2021

00/00/0000

00/00/0000

Exit

IPO

Acquired - II

IPO

Subscribe to see more

Subscribe to see more

Companies

Subscribe to see more

Subscribe to see more

Valuation

$991

$991

$991

Acquirer

Subscribe to see more

Subscribe to see more

Sources

3

2

1

10

10

China Renaissance Acquisitions

3 Acquisitions

China Renaissance acquired 3 companies. Their latest acquisition was IT Juzi on February 20, 2019.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

2/20/2019

Incubator/Accelerator

Acquired

1

5/3/2017

Subscribe to see more

$991

$99M

Subscribe to see more

10

5/2/2017

Subscribe to see more

$99M

Subscribe to see more

10

Date

2/20/2019

5/3/2017

5/2/2017

Investment Stage

Incubator/Accelerator

Companies

Subscribe to see more

Subscribe to see more

Valuation

$991

Total Funding

$99M

$99M

Note

Acquired

Subscribe to see more

Subscribe to see more

Sources

1

10

10

China Renaissance Fund History

12 Fund Histories

China Renaissance has 12 funds, including Huaxing Growth Capital IV.

Closing Date

Fund

Fund Type

Status

Amount

Sources

10/11/2021

Huaxing Growth Capital IV

$550M

1

9/10/2020

華興新經濟基金 (Huaxing Growth Capital USD Fund III)

$600M

2

7/29/2019

Huaxing Growth Capital III (华兴新经济基金第三期)

$942.93M

5

11/27/2017

Huaxing Medical Industry Fund

Subscribe to see more

$99M

10

1/15/2015

Shanghai Huasheng Lingshi Venture Investment LP

Subscribe to see more

$99M

10

Closing Date

10/11/2021

9/10/2020

7/29/2019

11/27/2017

1/15/2015

Fund

Huaxing Growth Capital IV

華興新經濟基金 (Huaxing Growth Capital USD Fund III)

Huaxing Growth Capital III (华兴新经济基金第三期)

Huaxing Medical Industry Fund

Shanghai Huasheng Lingshi Venture Investment LP

Fund Type

Subscribe to see more

Subscribe to see more

Status

Amount

$550M

$600M

$942.93M

$99M

$99M

Sources

1

2

5

10

10

China Renaissance Partners & Customers

5 Partners and customers

China Renaissance has 5 strategic partners and customers. China Renaissance recently partnered with Broadridge Financial Solutions on July 7, 2021.

Date

Type

Business Partner

Country

News Snippet

Sources

7/6/2021

Vendor

Broadridge Financial Solutions

United States

19:00 ET China Renaissance Selects Broadridge to Expand Post-trade Processing via Stock Connect

NEW YORK , July 6 , 2021 / PRNewswire / -- To facilitate the clearing and settlement of both Shenzhen - and Shanghai-listed equities , China Renaissance has expanded its post-trade processing relationship with Broadridge Financial Solutions , Inc. .

2

2/5/2021

Sponsored

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

6/18/2020

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

3/14/2019

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

3/27/2017

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

7/6/2021

2/5/2021

6/18/2020

3/14/2019

3/27/2017

Type

Vendor

Sponsored

Partner

Partner

Partner

Business Partner

Broadridge Financial Solutions

Country

United States

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

News Snippet

19:00 ET China Renaissance Selects Broadridge to Expand Post-trade Processing via Stock Connect

NEW YORK , July 6 , 2021 / PRNewswire / -- To facilitate the clearing and settlement of both Shenzhen - and Shanghai-listed equities , China Renaissance has expanded its post-trade processing relationship with Broadridge Financial Solutions , Inc. .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

10

10

10

10

China Renaissance Team

15 Team Members

China Renaissance has 15 team members, including current Founder, Chief Executive Officer, Fan Bao.

Name

Work History

Title

Status

Fan Bao

AsiaInfo Technologies, Morgan Stanley, Credit Suisse, and Credit Suisse First Boston

Founder, Chief Executive Officer

Current

Fan Bao

Chief Executive Officer

Current

Christine Low

Chief Operating Officer

Current

Frank Au

Managing Director

Current

Yang Diao

Managing Director

Current

Name

Fan Bao

Fan Bao

Christine Low

Frank Au

Yang Diao

Work History

AsiaInfo Technologies, Morgan Stanley, Credit Suisse, and Credit Suisse First Boston

Title

Founder, Chief Executive Officer

Chief Executive Officer

Chief Operating Officer

Managing Director

Managing Director

Status

Current

Current

Current

Current

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.